Seattle, WA · Founded 2014 · Privately Held (backing)
Operator of a biologic therapeutics company intended to treat serious diseases through advanced protein engineering. Cyrus Biotechnology is based in Seattle, WA and was founded in 2014. Its last reported valuation was $45.5 million in Oct 2021. It has raised $36.6 million across 10 recorded rounds; the latest was a $1.5 million seed round in Jul 2025.
Last reported valuation
$45.5M
Oct 2026
Priced at
—
Total raised
$36.6M
Last round
Seed Round
Jul 2025
Cap table — not yet on record
Cyrus Biotechnology's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cyrus Biotechnology with a free account
·The complete investor list: 26 names
·Watch Cyrus Biotechnology: the Monday email on marks, rounds and moves
Where does Cyrus Biotechnology's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cyrus Biotechnology's 10 recorded funding rounds.
